P88 Thalidomide as treatment for IPF associated cough
نویسندگان
چکیده
منابع مشابه
Thalidomide as a potential treatment for scleromyxedema.
A 39-year-old African American woman was referred in April 1995 with a 1-year history of skin thickening. The process began on her hands and progressed to involve her arms, face, neck, shoulders, chest, and proximal extremities. Her only systemic complaints were limited mobility of her joints, particularly her hands and wrists. Physical examination findings revealed leonine facies. The skin of ...
متن کاملRecommendations on treatment for IPF
Patient management in Idiopathic Pulmonary Fibrosis (IPF) is largely based on societal guidelines and recommendations. A recent update by the American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS) and Latin American Thoracic Association (ALAT) provided updated guidance on the diagnosis and management of IPF, along with recommendations on pharmaco...
متن کاملThalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disorder of unknown aetiology that leads to death in the majority of patients within 3–5 years of diagnosis. One of the most prominent features of IPF is a persistent dry cough that affects 73–86% of patients. The aetiology of the cough is unknown but presumably linked to the lung fibrosis. Unfortunately, the cough is often disabling and...
متن کاملThalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis.
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disorder of unknown aetiology that leads to death in the majority of patients within 3–5 years of diagnosis. One of the most prominent features of IPF is a persistent dry cough that affects 73–86% of patients. The aetiology of the cough is unknown but presumably linked to the lung fibrosis. Unfortunately, the cough is often disabling and...
متن کاملGabapentin as a potential treatment for cough syncope.
Chronic cough, defined as cough lasting for 8 weeks, is one of the most common symptoms of medical importance, and the prevalence in the community is 9–33%.1 A subgroup of patients suffer from the debilitating and distressing disorder of cough syncope, which is difficult to effectively manage and treat. The approach in clinic is to determine an underlying etiology for cough syncope and to treat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Thorax
سال: 2011
ISSN: 0040-6376
DOI: 10.1136/thoraxjnl-2011-201054c.88